Clinical Trial Update: Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled registry trial evaluating a 'blend to limit oxygen' strategy during ECMO in patients with heart failure and critical illness has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Heart Failure

Drugs mentioned

• Blend to Limit Oxygen in ECMO

Snippet

Sponsor: Australian and New Zealand Intensive Care Research Centre | Conditions: Cardiac Failure, Critical Illness | Phase 2 | Status: COMPLETED